{"name":"Amitriptyline for painful HIV-SN","tagline":"Data from the clinical trial: \"To determine the effectiveness of amitriptyline compared to placebo in the management of moderate to severe HIV related peripheral neuropathy\" (DOI 10.1186/ISRCTN54452526)","body":"# Amitriptyline.HIVSN\r\nData from clinical trial \"To determine the effectiveness of amitriptyline compared to placebo in the management of moderate to severe HIV related peripheral neuropathy\" (DOI 10.1186/ISRCTN54452526)\r\n- - - \r\nAll pain intensity data recorded on an 11-point numerical pain rating scale (0 = no pain, 10 = worst pain ever experienced)   \r\n- - - \r\n## Data key  \r\n### Demographics.csv (NA = missing data)\r\nBasic demographic information on the cohort at baseline\r\n* ID: Participant code\r\n* Age: Age in years\r\n* Female: Self-declared female sex\r\n* CD4: Latest CD4 T-cell count (cells/mm^3)  \r\n* ART: Antiretroviral use (any regimen)\r\n* D4T_ever: Ever used stavudine\r\n* D4T_now: Currently using stavudine\r\n* D4T_previously: Not currently using stavudine\r\n* Education_>9yrs: Nine years or greater of formal education\t\r\n* Employed: Any formal employment     \r\n\r\n### Baseline.csv \r\nBaseline pain data\r\n* ID: Participant code\r\n* ARV: On antiretroviral therapy\r\n* Period: First (week 1-6) or second (week 9-15) period of treatment \r\n* Treatment: P = Placebo, A = Amitriptyline\r\n* Pain: Pain intensity rating     \r\n\r\n### NNT.csv\r\nNumber needed to treat data\r\n* ID: Participant code\r\n* ARV: On antiretroviral therapy\r\n* Period: First (week 1-6) or second (week 9-15) period of treatment \r\n* Treatment: P = Placebo, A = Amitriptyline\r\n* Time1/Time2/Time3: Pain intensity rating on week 1, 3 and 6 of each treatment period\r\n* PercentDelta: Percentage change in pain intensity between week 1 and 6   \r\n\r\n### Dose.csv\r\nMaximum dose of drug/placebo during each treatment period\r\n* ID: Participant code\r\n* ARV: On antiretroviral therapy\r\n* Period: First (week 1-6) or second (week 9-15) period of treatment \r\n* Dose: Dose of amitriptyline or placebo (hypothetical dose based on number of placebo tables taken) (mg/day) \r\n* Tablets: Number of tablets of amitriptyline (25mg/tablet) or placebo taken per day   \r\n\r\n### Pain change.csv\r\nChange in pain between the start and end each six-week trial period\r\n* ID: Participant code\r\n* ARV: On antiretroviral therapy\r\n* DeltaPlacebo: Change in pain intensity rating when taking placebo\r\n* DeltaAmi: Change in pain intensity rating when taking amitriptyline\r\n* DeltaP.A: Difference in between DeltaAmi and DeltaPlacebo (negative numbers indicate greater pain relief on placebo compared to amitriptyline)   \r\n\r\n### Pain.csv\r\nPain intensity ratings on week 1,3,and 6 of each treatment period\r\n* ID: Participant code\r\n* ARV: On antiretroviral therapy\r\n* Period: First (week 1-6) or second (week 9-15) period of treatment \r\n* Treatment: P = Placebo, A = Amitriptyline\r\n* Week0/Week3/Week6: Pain intensity rating on week 1, 3 and 6 of each treatment period   \r\n\r\n### Rescue meds.csv\r\nRescue medications taken when receiving placebo and amitriptyline\r\n* ID: Participants code\r\n* Placebo.taken: Rescue medication (any) taken when receiving placebo\r\n* Placebo.para: Paracetamol taken when receiving placebo\r\n* Placebo.nsaids: Non-steroidal anti-inflammatory drugs taken when receiving placebo\r\n* Placebo.cod.para: Codeine and paracetamol combination taken when receiving placebo\r\n* Placebo.caf.asa.para: Caffeine, aspirin and paracetamol taken when receiving placebo\r\n* Ami.taken: Rescue medication (any) taken when receiving amitriptyline\r\n* Ami.para: Paracetamol taken when receiving amitriptyline\r\n* Ami.nsaids: Non-steroidal anti-inflammatory drugs taken when receiving amitriptyline\r\n* Ami.cod.para: Codeine and paracetamol combination taken when receiving amitriptyline\r\n* Ami.caf.asa.para: Caffeine, aspirin and paracetamol taken when receiving amitriptyline   \r\n\r\n### Responder.analysis.csv\r\nDemographic and phenotypic characteristics of responders and non-responders to amitriptyline treatment (>50% pain relief compared to when taking placebo)\r\n* ID: Participant code\r\n* Responder: Classed as a respnder or non-responder to amitriptyline treatment\r\n* ARV: On antiretroviral therapy (any)\r\n* Order: Order of treatment - PA = Placebo then Amitriptyline, AP = Amitriptyline then Placebo\r\n* Age: Age in years\r\n* Female: Self-declared female sex\r\n* CD4: Latest CD4 T-cell count (cells/mm^3)  \r\n* D4T_ever: Ever used stavudine\r\n* D4T_now: Currently using stavudine\r\n* D4T_previously: Not currently using stavudine\r\n* Education_>9yrs: Nine years or greater of formal education\t\r\n* Employed: Any formal employment\r\n* Burning: Pain reported as having burning quality\r\n* Painful.cold: Pain reported as having cold quality\r\n* Electric.shocks: Pain reported as have shock-like quality\r\n* Tingling: Pain reported as having a tingling quality\r\n* Pins.n.needles: Pain reported to feel like pins-and-needles\r\n* Numbness: Pain associated with numbness\r\n* Itching: Pain associated with itching sensation\r\n* Touch.hypoesthesia: Reduced/absent touch sensation of light touch\r\n* Pin.prick.hypoesthesia: Reduced/absent ability to distinguish sharp and blunt stimuli\r\n* Brush.allodynia: Hypersensitivity to brushing the skin gently   \r\n\r\n### Side effects.cv\r\nSide effects reported when receiving amitriptyline or placebo\r\n* ID: Participant code\r\n* Placebo.DryMouth: Reported having a dry mouth when receiving placebo\r\n* Placebo.Drowsy: Reported feeling drowsy when receiving placebo\r\n* Placebo.ChestPain: Reported experiencing chest pain (nonspecific) when receiving placebo\r\n* Ami.DryMouth: Reported having a dry mouth when receiving amitriptyline\t\r\n* Ami.Drowsy: Reported feeling drowsy when receiving amitriptyline\t\r\n* Ami.ChestPain: Reported experiencing chest pain (nonspecific) when receiving amitriptyline   \r\n\r\n### xover.BOCF.csv & xover.PP.csv\r\nPain intensity data for the complete dataset (n = 124, baseline carried forward for participants with missing data), and the reduced dataset (n = 122, completed study per protocol)\r\n* ID: Participant code\r\n* ARV: On antiretroviral therapy\r\n* Order: Order of treatment - PA = Placebo then Amitriptyline, AP = Amitriptyline then Placebo\r\n* Period: First (week 1-6) or second (week 9-15) period of treatment \r\n* Treatment: P = Placebo, A = Amitriptyline\r\n* Time1/Time2/Time3: Pain intensity rating on week 1, 3 and 6 of each treatment period   \r\n- - - \r\n\r\n  \r\n \r\n\r\n\r\n  \r\n \r\n","google":"","note":"Don't delete this file! It's used internally to help with page regeneration."}